130 related articles for article (PubMed ID: 12739139)
81. Mutational analysis of SHOC2, a novel gene for Noonan-like syndrome, in JMML.
Flotho C; Batz C; Hasle H; Bergsträsser E; van den Heuvel-Eibrink MM; Zecca M; Niemeyer CM; Zenker M
Blood; 2010 Jan; 115(4):913. PubMed ID: 20110435
[No Abstract] [Full Text] [Related]
82. The craniocardioskeletal syndrome and the Noonan-like short stature syndrome are possibly the same entity.
Sánchez Corona J; Cantú JM
J Med Genet; 1987 Aug; 24(8):510-1. PubMed ID: 3656378
[No Abstract] [Full Text] [Related]
83. [A woman behind the Noonan syndrome. She described a hereditary disease in children with congenital heart defects].
Wettrell G; Tollig H
Lakartidningen; 1996 Jan; 93(5):382-5. PubMed ID: 8628073
[No Abstract] [Full Text] [Related]
84. Identification of a novel EYA1 mutation presenting in a newborn with laryngomalacia, glossoptosis, retrognathia, and pectus excavatum.
Spruijt L; Hoefsloot LH; van Schaijk GH; van Waardenburg D; Kremer B; Brackel HJ; de Die-Smulders CE
Am J Med Genet A; 2006 Jun; 140(12):1343-5. PubMed ID: 16691597
[No Abstract] [Full Text] [Related]
85. Detailed mapping, mutation analysis, and intragenic polymorphism identification in candidate Noonan syndrome genes MYL2, DCN, EPS8, and RPL6.
Ion A; Crosby AH; Kremer H; Kenmochi N; Van Reen M; Fenske C; Van Der Burgt I; Brunner HG; Montgomery K; Kucherlapati RS; Patton MA; Page C; Mariman E; Jeffery S
J Med Genet; 2000 Nov; 37(11):884-6. PubMed ID: 11185075
[No Abstract] [Full Text] [Related]
86. A common cause of congenital heart disease.
Church A; Dubrey SW
Postgrad Med J; 2007 Nov; 83(985):e6. PubMed ID: 17989262
[No Abstract] [Full Text] [Related]
87. Abnormal phenotype in a child with the same balanced translocation (5;7)(p15;q22) as his father.
Caballín MR; Miró R; Egozcue J
Clin Genet; 1981 Dec; 20(6):428-31. PubMed ID: 7337958
[No Abstract] [Full Text] [Related]
88. SMG9-deficiency syndrome caused by a homozygous missense variant: Expanding the genotypic and phenotypic spectrum of this developmental disorder.
Lemire G; MacDonald SK; Boycott KM
Am J Med Genet A; 2020 Jul; 182(7):1829-1831. PubMed ID: 32412169
[No Abstract] [Full Text] [Related]
89. Congenital heart defects in Noonan syndrome and RIT1 mutation.
Calcagni G; Baban A; Lepri FR; Marino B; Tartaglia M; Digilio MC
Genet Med; 2016 Dec; 18(12):1320. PubMed ID: 27684039
[No Abstract] [Full Text] [Related]
90. RCSB Protein Data Bank: visualizing groups of experimentally determined PDB structures alongside computed structure models of proteins.
Segura J; Rose Y; Bi C; Duarte J; Burley SK; Bittrich S
Front Bioinform; 2023; 3():1311287. PubMed ID: 38111685
[TBL] [Abstract][Full Text] [Related]
91. SHP2 clinical phenotype, cancer, or RASopathies, can be predicted by mutant conformational propensities.
Liu Y; Zhang W; Jang H; Nussinov R
Cell Mol Life Sci; 2023 Dec; 81(1):5. PubMed ID: 38085330
[TBL] [Abstract][Full Text] [Related]
92. Inside the Noonan "universe": Literature review on growth, GH/IGF axis and rhGH treatment: Facts and concerns.
Stagi S; Ferrari V; Ferrari M; Priolo M; Tartaglia M
Front Endocrinol (Lausanne); 2022; 13():951331. PubMed ID: 36060964
[TBL] [Abstract][Full Text] [Related]
93. Noonan syndrome - a new survey.
Tafazoli A; Eshraghi P; Koleti ZK; Abbaszadegan M
Arch Med Sci; 2017 Feb; 13(1):215-222. PubMed ID: 28144274
[TBL] [Abstract][Full Text] [Related]
94. Cancer risk in patients with Noonan syndrome carrying a PTPN11 mutation.
Jongmans MC; van der Burgt I; Hoogerbrugge PM; Noordam K; Yntema HG; Nillesen WM; Kuiper RP; Ligtenberg MJ; van Kessel AG; van Krieken JH; Kiemeney LA; Hoogerbrugge N
Eur J Hum Genet; 2011 Aug; 19(8):870-4. PubMed ID: 21407260
[TBL] [Abstract][Full Text] [Related]
95. Diversity and functional consequences of germline and somatic PTPN11 mutations in human disease.
Tartaglia M; Martinelli S; Stella L; Bocchinfuso G; Flex E; Cordeddu V; Zampino G; Burgt Iv; Palleschi A; Petrucci TC; Sorcini M; Schoch C; Foa R; Emanuel PD; Gelb BD
Am J Hum Genet; 2006 Feb; 78(2):279-90. PubMed ID: 16358218
[TBL] [Abstract][Full Text] [Related]
96. Functional analysis of PTPN11/SHP-2 mutants identified in Noonan syndrome and childhood leukemia.
Niihori T; Aoki Y; Ohashi H; Kurosawa K; Kondoh T; Ishikiriyama S; Kawame H; Kamasaki H; Yamanaka T; Takada F; Nishio K; Sakurai M; Tamai H; Nagashima T; Suzuki Y; Kure S; Fujii K; Imaizumi M; Matsubara Y
J Hum Genet; 2005; 50(4):192-202. PubMed ID: 15834506
[TBL] [Abstract][Full Text] [Related]
97. Paternal germline origin and sex-ratio distortion in transmission of PTPN11 mutations in Noonan syndrome.
Tartaglia M; Cordeddu V; Chang H; Shaw A; Kalidas K; Crosby A; Patton MA; Sorcini M; van der Burgt I; Jeffery S; Gelb BD
Am J Hum Genet; 2004 Sep; 75(3):492-7. PubMed ID: 15248152
[TBL] [Abstract][Full Text] [Related]
98. Noonan syndrome with leukaemoid reaction and overproduction of catecholamines: a case report.
Kondoh T; Ishii E; Aoki Y; Shimizu T; Zaitsu M; Matsubara Y; Moriuchi H
Eur J Pediatr; 2003 Jul; 162(7-8):548-549. PubMed ID: 12739139
[No Abstract] [Full Text] [Related]
99. [Clinical symptoms and molecular pathogenesis of Noonan syndrome--current concepts].
Klapecki J; Obersztyn E; Laniewski-Wollk M; Szpecht-Potocka A; Mazurczak T
Med Wieku Rozwoj; 2006; 10(1 Pt 2):289-308. PubMed ID: 17028394
[TBL] [Abstract][Full Text] [Related]
100. [Noonan syndrome and Leopard syndrome linked to mutation of the gene PTPN11].
Dereure O
Ann Dermatol Venereol; 2005 Apr; 132(4):400. PubMed ID: 15886577
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
